| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 医药贸易(元) | 28,117,759.38 | 13,620,586.33 | 170,229,736.71 | 97,450,390.79 |
| 医药制造(元) | 110,829,704.14 | 50,429,159.04 | 176,080,306.62 | 114,125,437.90 |
| 营业成本(元) | ||||
| 医药贸易(元) | 27,369,493.02 | 13,338,788.75 | 168,168,147.70 | 96,041,917.11 |
| 医药制造(元) | 23,843,140.74 | 10,455,927.35 | 24,968,831.60 | 16,275,748.75 |
| 毛利(元) | ||||
| 医药贸易(元) | 748,266.36 | 281,797.58 | 2,061,589.01 | 1,408,473.68 |
| 医药制造(元) | 86,986,563.40 | 39,973,231.69 | 151,111,475.02 | 97,849,689.15 |
| 毛利率(%) | ||||
| 医药贸易(%) | 2.66 | 2.07 | 1.21 | 1.45 |
| 医药制造(%) | 78.49 | 79.27 | 85.82 | 85.74 |
| 收入构成(%) | ||||
| 医药贸易(%) | 20.24 | 21.27 | 49.16 | 46.06 |
| 医药制造(%) | 79.76 | 78.73 | 50.84 | 53.94 |
| 毛利构成(%) | ||||
| 医药贸易(%) | 0.85 | 0.70 | 1.35 | 1.42 |
| 医药制造(%) | 99.15 | 99.30 | 98.65 | 98.58 |